EE9900332A - 1-[4-(3-trifluorometüülfenüül)-1,2,3,6-tetrahüdropüriid-1-üül]-2-(6,7-dimetoksünaft-2- üül)etaani kasutamine neurotroopse toimega ravimite valmistamiseks - Google Patents

1-[4-(3-trifluorometüülfenüül)-1,2,3,6-tetrahüdropüriid-1-üül]-2-(6,7-dimetoksünaft-2- üül)etaani kasutamine neurotroopse toimega ravimite valmistamiseks

Info

Publication number
EE9900332A
EE9900332A EEP199900332A EE9900332A EE9900332A EE 9900332 A EE9900332 A EE 9900332A EE P199900332 A EEP199900332 A EE P199900332A EE 9900332 A EE9900332 A EE 9900332A EE 9900332 A EE9900332 A EE 9900332A
Authority
EE
Estonia
Prior art keywords
dimethoxynaphth
tetrahydropyrid
trifluoromethylphenyl
ethane
drugs
Prior art date
Application number
EEP199900332A
Other languages
English (en)
Inventor
Croci Tiziano
Fournier Jacqueline
Guzzi Umberto
Palmieri Costantino
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE9900332A publication Critical patent/EE9900332A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
EEP199900332A 1997-02-03 1997-02-03 1-[4-(3-trifluorometüülfenüül)-1,2,3,6-tetrahüdropüriid-1-üül]-2-(6,7-dimetoksünaft-2- üül)etaani kasutamine neurotroopse toimega ravimite valmistamiseks EE9900332A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR1997/000202 WO1998033502A1 (fr) 1997-02-03 1997-02-03 Utilisation du 1-[4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimethoxynapht-2-yl)ethane pour la preparation de medicaments destines aux traitements de troubles cerebraux et neuronaux

Publications (1)

Publication Number Publication Date
EE9900332A true EE9900332A (et) 2000-02-15

Family

ID=9502506

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900332A EE9900332A (et) 1997-02-03 1997-02-03 1-[4-(3-trifluorometüülfenüül)-1,2,3,6-tetrahüdropüriid-1-üül]-2-(6,7-dimetoksünaft-2- üül)etaani kasutamine neurotroopse toimega ravimite valmistamiseks

Country Status (11)

Country Link
EP (1) EP0954311A1 (et)
JP (1) JP2001511141A (et)
AU (1) AU1607397A (et)
CA (1) CA2279326A1 (et)
CZ (1) CZ275399A3 (et)
EE (1) EE9900332A (et)
HU (1) HUP0000767A3 (et)
IL (1) IL130994A0 (et)
IS (1) IS5117A (et)
TR (1) TR199901722T2 (et)
WO (1) WO1998033502A1 (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6272180B1 (en) * 1997-11-21 2001-08-07 Sharp Laboratories Of America, Inc. Compression and decompression of reference frames in a video decoder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5618822A (en) * 1990-05-23 1997-04-08 Sanofi N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
JP2001511141A (ja) 2001-08-07
HUP0000767A2 (hu) 2000-09-28
EP0954311A1 (fr) 1999-11-10
IL130994A0 (en) 2001-01-28
IS5117A (is) 1999-07-15
TR199901722T2 (xx) 2000-08-21
CZ275399A3 (cs) 1999-12-15
WO1998033502A1 (fr) 1998-08-06
AU1607397A (en) 1998-08-25
CA2279326A1 (fr) 1998-08-06
HUP0000767A3 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
DE69826368D1 (de) Kapazitiv angekoppeltes, schnurloses, elektrochirurgisches Instrument
ATE408396T1 (de) Eine kosmetische zubereitung die antagonisten des neuropeptid-y-rezeptors enthaltet
MX209959B (es) 4-(3-heterociclil-1-benzoil)pirazoles
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
DK1007017T3 (da) Ny formulering til inhalering, som har en hældebulkdensitet på 0,28 til 0,38 g/ml, en fremgangsmåde til fremstilling af formuleringen og anvendelsen deraf
IT1277601B1 (it) Prodotto farmaceutico a base di 4-(2-piperidinoetossi)benzoil- benzo/b/tiofene sostituito
DE60021099D1 (de) Transdermale, in form einer haftschicht ausgebildete zweifachmedikamenten-verabreichungsvorrichtung
NO981893D0 (no) Polymerblandingsmatriks med vedvarende frigiving for farmas÷ytisk anvendelse
BR9810829B1 (pt) composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
EE200000171A (et) Uued NPY antagonistid
NO20004668D0 (no) 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister
NL1010242A1 (nl) Zwabberkop.
EE200000022A (et) Uus ravimvorm
FI20002168A (fi) Pietsosähköinen oskillaattori
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
DE60024577D1 (de) Piezoelektrischer oszillator
FI964212A (fi) Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväksyttäviä savia
EE9900332A (et) 1-[4-(3-trifluorometüülfenüül)-1,2,3,6-tetrahüdropüriid-1-üül]-2-(6,7-dimetoksünaft-2- üül)etaani kasutamine neurotroopse toimega ravimite valmistamiseks
ID19694A (id) Alat sikat, khususnya sikat gigi, dan kemasan untuknya
ID21499A (id) Proses untuk memproduksi n-(4-fluorofenil)-n-(1-metiletil)-2-[(5-(trifluorometil)-1,3,4-tiadiazol-2-il)-oksi]-asetamida
IL129647A0 (en) Substituted 4-(6-fluoro-(1H)-indol-3-YL)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders
FI953720A0 (fi) Neurotensiiniantagonistien käyttö diureettietan lääkkeiden valmistamiseksi
FR2800589B1 (fr) Fauteuil articule a usage medical, pour handicapes et pour le relaxation
FI955523A0 (fi) 1-(2-bentsimidatsolyyli)-1,5-diatsasyklo-oksataaniyhdisteet
HUP0203476A3 (en) Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate, use thereof and pharmaceutical composition containing the same